FDA units strict limits on Johnson & Johnson Covid-19 vaccine

The FDA mentioned in an announcement that the change is being made due to the danger of a uncommon and harmful clotting situation known as thrombosis with thrombocytopenia syndrome (TTS) after receiving the vaccine. “Now we have intently monitored the Janssen COVID-19 vaccine and the incidence of TTS after administration and used up to date …

FDA units strict limits on Johnson & Johnson Covid-19 vaccine Read More »